146427 -OEChem-03010813452D 8 0 0 0 0 0 0 0 0999 V2000 -0.0250 1.2500 0.0000 * 0 0 0 0 0 0 0 0 0 0 0 0 -0.0250 0.7500 0.0000 * 0 0 0 0 0 0 0 0 0 0 0 0 -0.0250 0.2500 0.0000 * 0 0 0 0 0 0 0 0 0 0 0 0 -0.0250 -0.2500 0.0000 * 0 0 0 0 0 0 0 0 0 0 0 0 -0.0250 -0.7500 0.0000 * 0 0 0 0 0 0 0 0 0 0 0 0 -0.0250 -1.2500 0.0000 * 0 0 0 0 0 0 0 0 0 0 0 0 -0.0250 -1.7500 0.0000 * 0 0 0 0 0 0 0 0 0 0 0 0 -0.0250 -2.2500 0.0000 * 0 0 0 0 0 0 0 0 0 0 0 0 A 1 R A 2 R A 3 R A 4 R A 5 R A 6 R A 7 R A 8 R M END > 0 > 0 > 146427 > 1 > DTP/NCI > 294735 > Development Therapeutics Program NCI/NIH > Composition for every 0.2 ml H(2)O: 3.68 mg sodium sulfite, KOH to pH 9.3-9.5, 0.051 mg p-tert butyl catechol, 0.007 mg 1, 2-naphthoquinone, 0.442 mg catechol, 0.147 mg 2,5-dihydroxy p-quinone, 0.735 mg tetrahydroxyquinone, 0.882 mg tetrahydroxyquinone polymer, 0.243 mg croconic acid, 0.493 mg croconic acid polymer NSC294735 > NSC294735 > http://dtp.nci.nih.gov/ > http://dtp.nci.nih.gov/dtpstandard/servlet/dwindex?searchtype=NSC&outputformat=html&searchlist=294735 $$$$